© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 9, 790-796,
May 5, 1999
© 1999 Oxford University Press
REPORTS |
Possible Role of Calponin h1 as a Tumor Suppressor in Human Uterine Leiomyosarcoma
Affiliations of authors: A. Horiuchi, T. Nikaido (Department of Obstetrics and Gynecology), S. Taniguchi (Department of Molecular Oncology and Angiology), Shinshu University School of Medicine, Asahi, Matsumoto, Japan; S. Fujii, Department of Gynecology and Obstetrics, Kyoto University, Sakyo-ku, Japan.
Correspondence to: Toshio Nikaido, Ph.D., Department of Obstetrics and Gynecology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan (e-mail: tnikaido{at}hsp.md.shinshu-u.ac.jp).
BACKGROUND: Calponin h1, a basic actin-binding protein capable of inhibiting smooth muscle contraction, is a constitutive element of smooth muscle cells. However, in leiomyosarcoma (a type of smooth muscle neoplasm of the uterus), reduced expression of calponin h1 is observed, as we have reported previously. In this study, we sought to assess the effects (in vitro and in vivo) of increasing calponin h1 expression in leiomyosarcoma cells. METHODS: A plasmid containing a human calponin h1 complementary DNA and a bacterial neomycin-resistance gene was transfected into the human leiomyosarcoma cell lines SKN and SK-LMS-1 by electroporation. Southern blotting, reverse transcription-polymerase chain reaction analysis, western blotting, and immunohistochemistry were used to confirm DNA transfer and expression of the calponin h1 protein in neomycin-resistant clones. We characterized the morphology of calponin h1-transfected cells, and we evaluated their proliferative activity and tumorigenicity by use of a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide assay, an anchorage-independent growth assay, and a nude mouse tumorigenicity assay. RESULTS: The morphology of calponin h1-transfected cells in culture resembled that of cultured normal myometrial smooth muscle cells. With SK-LMS-1 cells, proliferation of calponin h1-transfection cells was reduced to 69% of control; with SKN cells, calponin h1 transfection reduced proliferation to 70% of control. In assays of anchorage-independent growth and in vivo tumorigenicity, both growth and tumorigenicity were statistically significantly reduced in calponin h1-transfected leiomyosarcoma cells. CONCLUSIONS: Calponin h1 may function as a tumor suppressor in leiomyosarcoma. Clinically, transfer of a calponin h1 complementary DNA into poorly differentiated leiomyosarcoma cells may be of potential therapeutic value through induction of a normal, differentiated cellular phenotype.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Okamoto, J. Li, A. O. Vortmeyer, H. Jaffe, Y.-S. Lee, S. Glasker, T.-S. Sohn, W. Zeng, B. Ikejiri, M. A. Proescholdt, et al. Comparative proteomic profiles of meningioma subtypes. Cancer Res., October 15, 2006; 66(20): 10199 - 10204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ogura, H. Kobayashi, Y. Ueoka, K. Okugawa, K. Kato, T. Hirakawa, S. Hashimoto, S. Taniguchi, N. Wake, and H. Nakano Adenovirus-Mediated Calponin h1 Gene Therapy Directed against Peritoneal Dissemination of Ovarian Cancer: Bifunctional Therapeutic Effects on Peritoneal Cell Layer and Cancer Cells Clin. Cancer Res., September 1, 2006; 12(17): 5216 - 5223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-G. Liu, L. Zhang, Y. Jiang, D. Chatterjee, C. M. Croce, K. Huebner, and L. Y.Y. Fong Modulation of Gene Expression in Precancerous Rat Esophagus by Dietary Zinc Deficit and Replenishment Cancer Res., September 1, 2005; 65(17): 7790 - 7799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Burgstaller and M. Gimona Actin cytoskeleton remodelling via local inhibition of contractility at discrete microdomains J. Cell Sci., January 15, 2004; 117(2): 223 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kaverina, T. E. B. Stradal, and M. Gimona Podosome formation in cultured A7r5 vascular smooth muscle cells requires Arp2/3-dependent de-novo actin polymerization at discrete microdomains J. Cell Sci., December 15, 2003; 116(24): 4915 - 4924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gimona, I. Kaverina, G. P. Resch, E. Vignal, and G. Burgstaller Calponin Repeats Regulate Actin Filament Stability and Formation of Podosomes in Smooth Muscle Cells Mol. Biol. Cell, June 1, 2003; 14(6): 2482 - 2491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Hossain, D.-Y. Hwang, Q.-Q. Huang, Y. Sasaki, and J.-P. Jin Developmentally regulated expression of calponin isoforms and the effect of h2-calponin on cell proliferation Am J Physiol Cell Physiol, January 1, 2003; 284(1): C156 - C167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Ueda, N Araki, M Mano, A Myoui, S Joyama, S Ishiguro, H Yamamura, K Takahashi, I Kudawara, and H Yoshikawa Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone J. Clin. Pathol., November 1, 2002; 55(11): 853 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sugenoya, A. Yoshimura, H. Yamamura, K. Inui, H. Morita, H. Yamabe, N. Ueki, T. Ideura, and K. Takahashi Smooth-Muscle Calponin in Mesangial Cells: Regulation of Expression and a Role in Suppressing Glomerulonephritis J. Am. Soc. Nephrol., February 1, 2002; 13(2): 322 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.'i. Taniguchi, M. Takeoka, T. Ehara, S. Hashimoto, H. Shibuki, N. Yoshimura, H. Shigematsu, K. Takahashi, and M. Katsuki Structural Fragility of Blood Vessels and Peritoneum in Calponin h1-deficient Mice, Resulting in an Increase in Hematogenous Metastasis and Peritoneal Dissemination of Malignant Tumor Cells Cancer Res., October 1, 2001; 61(20): 7627 - 7634. [Abstract] [Full Text] [PDF]
|
|